本页面由Tiger Trade Technology Pte. Ltd.提供服务

Mereo Biopharma Group Plc

0.3290
+0.00902.81%
盘后0.3281-0.0009-0.27%19:37 EDT
成交量:116.74万
成交额:37.53万
市值:5,235.43万
市盈率:-1.25
高:0.3348
开:0.3169
低:0.3119
收:0.3200
52周最高:3.05
52周最低:0.2000
股本:1.59亿
流通股本:1.00亿
量比:0.82
换手率:1.16%
股息:- -
股息率:- -
每股收益(TTM):-0.2629
每股收益(LYR):-0.2627
净资产收益率:-82.21%
总资产收益率:-39.41%
市净率:1.28
市盈率(LYR):-1.25

数据加载中...

2024/06/12

重要事件披露

Form 8-K - Current report
2024/05/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/23

重要事件披露

Form 8-K - Current report
2024/05/21

SEC问询函

Form CORRESP - Correspondence
2024/05/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/15

重要事件披露

Form 8-K - Current report
2024/04/16

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/04/15

重要事件披露

Form 8-K - Current report
2024/03/27

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/27

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/06

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/05

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/24

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/01/08

重要事件披露

Form 8-K - Current report
2023/11/20

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]